DSM completes acquisition of stake in Chinese firm Andre Pectin

摘要

ROYAL DSM, the global life sciences and materials sciences company, has completed the acquisition of a 19% equity interest in Yantai Andre Pectin Co Ltd (Andre Pectin), a China based producer of texturing ingredients. DSM announced this acquisition on 5 May 2013. DSM had previously acquired a 10% stake in Andre Pectin from Hony Capital. DSM's total interest in Andre Pectin is now 29%. The parties have agreed that DSM has option rights to increase its stake in Andre Pectin to a majority stake at a later stage.